Ceramide in apoptosis: A revisited role

Neurochemical Research

Volumn 27, Issue 7-8, 2002, Pages 601-607

  Levade, Thierry ^a   Malagarie Cazenave, Sophie ^a   Gouazé, Valérie ^a   Ségui, Bruno ^a   Tardy, Claudine ^a   Betito, Susan ^a   Andrieu Abadie, Nathalie ^a   Cuvillier, Olivier ^a  

^a CHU RANGUEIL   (France)

Author keywords

Apoptosis; Ceramide; FAN; Sphingomyelin; Sphingomyelinase; Sphingosine

Indexed keywords

CERAMIDE; SPHINGOLIPID;

APOPTOSIS; ARTICLE; CELL DEATH; CELL MEMBRANE; CELL POPULATION; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID ANALYSIS; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CERAMIDES; HUMANS;

EID: 0036695828     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020215815013     Document Type: Article

References (93)

1. Hengartner, M. O. 2000. The biochemistry of apoptosis. Nature 407:770-776.
2. Riboni, L., Viani, P., Bassi, R., Prinetti, A., and Tettamanti, G. 1997. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:153-195.
3. Kolesnick, R. N. and Krönke, M. 1998. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60:643-665.
4. Hannun, Y. A. and Luberto, C. 2000. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10:73-80.
5. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A. 1993. Programmed cell death induced by ceramide. Science 259:1769-1771.
6. Hofmann, K. and Dixit, V. M. 1998. Ceramide in apoptosis: does it really matter? Trends Biochem. Sci. 23:374-377.
7. Kolesnick, R. and Hannun, Y. A. 1999. Ceramide and apoptosis. Trends Biochem. Sci. 24:224-225.
8. Hofmann, K. and Dixit, V. M. 1999. Reply to Kolesnick and Hannun, and Perry and Hannun. Trends Biochem. Sci. 24:227.
9. Radin, N. S. 2001. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come? Eur. J. Biochem. 268:193-204.
10. Hannun, Y. A., Luberto, C., and Argraves, K. M. 2001. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40:4893-4903.
11. Levade, T., Augé, N., Veldman, R. J., Cuvillier, O., NègreSalvayre, A., and Salvayre, R. 2001. Sphingolipid mediators in cardiovascular cell biology and pathology. Circ. Res. 89:957-968.
12. Mathias, S., Pena, L. A., and Kolesnick, R. N. 1998. Signal transduction of stress via ceramide. Biochem. J. 335:465-480.
13. Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A. 1996. Bc1-2 interrupts the ceramide-mediated pathway of cell death. Proc, Natl. Acad. Sci. U.S.A. 93:5325- 5328.
14. Allouche, M., Bettaieb, A., Vindis, C., Rousse, A., Grignon, C., and Laurent, G. 1997. Influence of Bc1-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Oncogene 14:1837-1845.
15. Dbaibo, G. S., Perry, D. K., Gamard, C. J., Platt, R., Poirier, G. G., Obeid, L. M., and Hannun. Y. A. 1997. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-α: CrmA and Bc1-2 target distinct components in the apoptotic pathway. J. Exp. Med. 185:481-490.
16. Wiesner, D. A., Kilkus, J. P., Gottschalk, A. R., Quintans, J., and Dawson, G. 1997. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involve the slow formation of ceramide from sphingomyelin and is blocked by bcl-XL. J. Biol. Chem. 272: 9868-9876.
17. Jaffrézou, J. P., Maestre, N., de Mas-Mansat, V., Bezombes, C., Levade, T., and Laurent, G. 1998. Positive feedback control of neutral sphingomyelinase activity by ceramide. FASEB J. 12: 999-1006.
18. Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. 1999. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J. Clin. Invest. 103:971-978.
19. Cuvillier, O., Edsall, L., and Spiegel, S. 2000. Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J. Biol. Chem. 275:15691-15700.
20. Ji, L., Zhang, G., Uematsu, S., Akahori, Y., and Hirabayashi, Y. 1995. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358:211-214.
21. Sweeney, E. A., Sakakura, C., Shirahama, T., Masamune, A., Ohta, H., Hakomori, S., and Igarashi, Y. 1996. Sphingosine and its methylated derivative N, N-dimethylsphingosine (DMS) induce apoptosis in a variety of human cancer cell lines. Int. J. Cancer 66:358-366.
22. Bielawska, A., Crane, H. M., Liotta, D., Obeid, L. M., and Hannun, Y. A. 1993. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J. Biol. Chem. 268:26226-26232.
23. Zhang, P., Liu, B., Jenkins, G. M., Hannun, Y. A., and Obeid, L. M. 1997. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J. Biol. Chem. 272:9609-9612.
24. Birbes, H., El Bawab, S., Hannun, Y. A., and Obeid, L. M. 2001. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15:2669-2679.
25. Kanto, T., Kalinski, P., Hunter, O. C., Lotze, M. T., and Amoscato, A. A. 2001. Ceramide mediates tumor-induced dendritic cell apoptosis. J. Immunol. 167:3773-3784.
26. Selzner, M., Bielawska, A., Morse, M. A., Rudiger, H. A., Sindram, D., Hannun, Y. A., and Clavien, P. A. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61:1233-1240.
27. Nicholson, K. M., Quinn, D. M., Kellett, G. L., and Warr, J. R. 1999. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase. Br. J. Cancer 81:423-430.
28. Edsall, L. C., Pirianov, G. G., and Spiegel, S. 1997. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 17:6952-6960.
29. Xia, P., Wang, L., Gamble, J. R., and Vadas, M. A. 1999. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274:34499-34505.
30. Mandala, S. M., Thornton, R., Galve-Roperh, I., Poulton, S., Peterson, C., Olivera, A., Bergstrom, J., Kurtz, M. B., and Spiegel, S. 2000. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. U.S.A. 97:7859-7864.
31. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R. 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414.
32. Xu, J., Yeh, C. H., Chen, S., He, L., Sensi, S. L., Canzoniero, L. M., Choi, D. W., and Hsu, C. Y. 1998. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/ cycloheximide-induced cerebral endothelial cell death. J. Biol. Chem. 273:16521-16526.
33. Perry, D. K., Carton, J., Shah, A. K., Meredith, F., Uhlinger, D. J., and Hannun, Y. A. 2000. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 275:9078-9084.
34. Kroesen, B. J., Pettus, B., Luberto, C., Busman, M., Sietsma, H., de Leij, L., and Hannun, Y. A. 2001. Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J. Biol. Chem. 276:13606-13614.
35. Olivera, A., Kohama, T., Edsall, L., Nava, V., Cuvillier, O., Poulton, S., and Spiegel, S. 1999. Sphingosine kinase overexpression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell. Biol. 147: 545-557.
36. Edsall, L., Cuvillier, O., Twitty, S., Spiegel, S., and Milstien, S. 2001. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 76:1573-1584.
37. Liu, Y. Y., Han, T. Y., Giuliano, A. E., and Cabot, M. C. 2001. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J. 15:719-730.
38. Higuchi, M., Singh, S., Jaffrézou, J. P., and Aggarwal, B. B. 1996. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-KB activation. J. Immunol. 156:297-304.
39. Chen, J. K., Capdevila, J., and Harris, R. C. 2001. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol. Cell Biol. 21:6322-6331.
40. Brann, A. B., Tcherpakov, M., Williams, I. M., Futerman, A. H., and Fainzilber, M. 2002. NGF-induced p75-mediated death of cultured hippocampal neurons is age-dependent and transduced through ceramide generated by neutral sphingomyelinase. J. Biol. Chem. 277:9812-9818.
41. Oses-Prieto, J. A., Lopez-Moratalla, N., Santiago, E., Jaffrézou, J. P., and Lopez-Zabalza, M. J. 2000. Molecular mechanisms of apoptosis induced by an immunomodulating peptide on human monocytes. Arch. Biochem. Biophys. 379:353-362.
42. Sawada, M., Nakashima, S., Kiyono, T., Yamada, J., Hara, S., Nakagawa, M., Shinoda, J., and Sakai, N. 2002. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells. Exp. Cell Res. 273:157-168.
43. Ségui, B., Bezombes, C., Uro-Coste, E., Medin, J. A., AndrieuAbadie, N., Augé, N., Brouchet, A., Laurent, G., Salvayre, R., Jaffrézou, J. P., and Levade, T. 2000. Stress-induced apoptosis is not mediated by endolysosomal ceramide. FASEB J. 14:36-47.
44. Burek, C., Roth, J., Koch, H. G., Harzer, K., Los, M., and Schulze-Osthoff, K. 2001. The role of ceramide in receptor- and stress-induced apoptosis studied in acidic ceramidase-deficient Farber disease cells. Oncogene 20:6493-6502.
45. Luberto, C., Toffaletti, D. L., Wills, E. A., Tucker, S. C., Casadevall, A., Perfect, J. R., Hannun, Y. A., and Del Poeta, M. M. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 15:201-212.
46. Cheng, J., Park, T. S., Fischl, A. S., and Ye, X. S. 2001. Cell cycle progression and cell polarity require sphingolipid biosynthesis in Aspergillus nidulans. Mol. Cell Biol. 21:6198-6209.
47. Pronk, G. J., Ramer, K., Amiri, P., and Williams, L. T. 1996. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science, 271:808-810.
48. Adachi-Yamada, T., Gotoh, T., Sugimura, I., Tateno, M., Nishida, Y., Onuki, T., and Date, H. 1999. De novo synthesis of sphingolipids is required for cell survival by down-regulating c-Jun N-terminal kinase in Drosophila imaginal discs. Mol. Cell Biol. 19:7276-8726.
49. Wright, S. C., Zheng, H., and Zhong, J. 1996. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J. 10:325-332.
50. Cai, Z., Bettaieb, A., El Mahdani, N., Legres, L. G., Stancou, R., Masliab, J., and Chouaib, S. 1997. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicity. J. Biol. Chem. 272:6918-6926.
51. Chmura, S. J., Nodzenski, E., Beckett, M. A., Kufe, D. W., Quintans, J., and Weichselbaum, R. R. 1997. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 57:1270-1275.
52. Michael, J. M., Lavin, M. F., and Watters, D. J. 1997. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:3600-3605.
53. Bruno, A. P., Laurent, G., Averbeck, D., Demur, C., Bonnet, J., Bettaieb, A., Levade, T., and Jaffrézou, J. P. 1998. Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ. 5:172-182.
54. Wang, X. Z., Beebe, J. R., Pwiti, L., Bielawska, A., and Smyth, M. J. 1999. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res. 59:5842-5848.
55. Nava, V. E., Cuvillier, O., Edsall, L. C., Kimura, K., Milstien, S., Gelmann, E. P., and Spiegel, S. 2000. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60:4468-4474.
56. Haimovitz-Friedman, A., Kan, C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. 1994. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180:525-535.
57. Jarvis, W. D., Fornari, F. A., Gewirtz, D. A., Kolesnick, R. N., and Grant, S. 1994. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem. 269:31685-31692.
58. Mansat, V., Laurent, G., Levade, T., Bettaieb, A., and Jaffrézou, J. P. 1997. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res. 57:5300-5304.
59. Pena, L. A., Fuks, Z., and Kolesnick, R. N. 2000. Radiationinduced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res. 60:321-327.
60. Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., and Kolesnick, R. 2001. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293:293-297.
61. Bezombes, C., Maestre, N., Laurent, G., Levade, T., Bettaieb, A., and Jaffrézou, J. P. 1998. Restoration of TNF-α-induced ceramide generation and apoptosis in resistant human leukemia KGla cells by the P-glycoprotein blocker PSC833. FASEB J. 12:101-109.
62. Senchenkov, A., Litvak, D. A., and Cabot, M. C. 2001. Targeting ceramide metabolism-a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 93:347-357.
63. Santana, P., Pena, L. A., Haimovitz-Friedman, A., Martin, S., Green, D., McLoughlin, M., Cordon-Cardo, C., Schuchman, E. H., Fuks, Z., and Kolesnick, R. 1996. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199.
64. Haimovitz-Friedman, A., Cordon-Cardo, C., Bayoumy, S., Garzotto, M., McLoughlin, M., Gallily, R., Edwards, C. K., Schuchman, E. H., Fuks, Z., and Kolesnick, R. 1997. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 186:1831-1841.
65. de Maria, R., Rippo, M. R., Schuchman, E. H., and Testi, R. 1998. Acidic sphingomyelinase (ASM) is necessary for Fas induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J. Exp. Med. 187:897-902.
66. Kirschnek, S., Paris, F., Weller, M., Grassme, H., Ferlinz, K., Riehle, A., Fuks, Z., Kolesnick, R., and Gulbins, E. 2000. CD95-mediated apoptosis in vivo involves acid sphingomyelinase. J. Biol. Chem. 275:27316-27323.
67. Lozano, J., Menendez, S., Morales, A., Ehleiter, D., Liao, W. C., Wagman, R., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. 2001. Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts. J. Biol. Chem. 276:442-448.
68. Zhang, Y., Mattjus, P., Schmid, P. C., Dong, Z., Zhong, S., Ma, W. Y., Brown, R. E., Bode, A. M., and Schmid, H. H. 2001. Involvement of the acid sphingomyelinase pathway in UVA-induced apoptosis. J. Biol. Chem. 276:11775-11782.
69. Boesen de Cock, J. G. R., Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. 1998. CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J. Biol. Chem. 273:7560-7565.
70. Nix, M., and Stoffel, W. 2000. Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death Differ. 7:413-424.
71. Bezombes, C., Ségui, B., Cuvillier, O., Bruno, A. P., Uro-Coste, E., Gouazé, V., Andrieu-Abadie, N., Carpentier, S., Laurent, G., Salvayre, R., Jaffrézou, J. P., and Levade, T. 2001. Lysosomal sphingomyelinase is not solicited for apoptosis signaling. FASEB J. 15:297-299.
72. Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., and Krönke, M. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78: 1005-1015.
73. Cifone, M. G., Roncaioli, P., De Maria, R., Camarda, G., Santoni, A., Ruberti, G., and Testi, R. 1995. Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14:5859-5868.
74. Chinnaiyan, A. M., Tepper, C. G., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. 1996. FADD/MORTI is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:4961-4965.
75. Levade, T. and Jaffrézou, J. P. 1999. Signalling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta. 1438:1-17.
76. Jayadev, S., Hayter, H. L., Andrieu, N., Gamard, C. J., Liu, B., Balu, R., Hayakawa, M., Ito, F., and Hannun, Y. A. 1997. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J. Biol. Chem. 272:17196-17203.
77. Mansat, V., Bettaieb, A., Levade, T., Laurent, G., and Jaffr6zou, J. P. 1997. Serine protease inhibitors block neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. FASEB J. 11:695-702.
78. Bezombes, C., Plo, I., Mansat-De Mas, V., Quillet-Mary, A., Negre-Salvayre, A., Laurent, G., and Jaffrezou, J. P. 2001. Oxidative stress-induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C. FASEB J. 15:1583-1585.
79. Liu, B., Andrieu-Abadie, N., Levade, T., Zhang, P., Obeid, L. M. and Hannun, Y. A. 1998. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J. Biol. Chem. 273:11313-11320.
80. Gouazé, V., Mirault, M. E., Carpentier, S., Salvayre, R., Levade, T., and Andrieu-Abadie, N. 2001. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol. Pharmacol. 60:488-496.
81. Adam, D., Wiegmann, K., Adam-Klages, S., Ruff, A., and Krönke, M. 1996. A novel cytoplasmic domain of the p55 Tumor Necrosis Factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 1996:14617-14622.
82. Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., and Krönke, M. 1996. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:937-947.
83. Kreder, D., Krut, O., Adam-Klages, S., Wiegmann, K., Scherer, G., Plitz, T., Jensen, J. M., Proksch, E., Steinmann, J., Pfeffer, K., and Krönke, M. 1999. Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18:2472-2479.
84. Ségui, B., Andrieu-Abadie, N., Adam-Klages, S., Meilhac, O., Kreder, D., Garcia, V., Bruno, A. P., Jaffrézou, J. P., Salvayre, R., Krönke, M., and Levade, T. 1999. CD40 signals apoptosis through FAN-regulated activation of the sphingomyelinceramide pathway. J. Biol. Chem. 274:37251-37258.
85. Ségui, B., Cuvillier, O., Adam-Klages, S., Garcia, V., Malagarie-Cazenave, S., Lévêque, S., Caspar-Bauguil, S., Coudert, J., Salvayre, R., Krönke, M., and Levade, T. 2001. Involvement of FAN in tumor necrosis factor-induced apoptosis. J. Clin. Invest. 108:143-151.
86. Lee, T. C., Ou, M. C., Shinozaki, K., Malone, B., and Snyder, F. 1996. Biosynthesis of N-acetylsphingosine by plateletactivating factor: sphingosine CoA-independent transacetylase in HL-60 cells. J. Biol. Chem. 271:209-217.
87. Holopainen, J. M., Angelova, M. I., and Kinnunen, P. K. 2000. Vectorial budding of vesicles by asymmetrical enzymatic formation of ceramide in giant liposomes. Biophys. J. 78:830-838.
88. Kolesnick, R. N., Goni, F. M., and Alonsg, A. 2000. Compartmentalizatign of ceramide signaling: physical foundations and biological effects. J. Cell Physiol. 184:285-300.
89. Zha, X., Pierini, L. M., Leopold, P. L., Skiba, P. J., Tabas, I., and Maxfield, F. R. 1998. Sphingomyelinase treatment induces ATP-independent endocytosis. J. Cell Biol. 140:39-47.
90. Cremesti, A., Paris, F., Grassme, H., Holler, N., Tschopp, J., Fuks, Z., Gulbins, E., and Kolesnick, R. 2001. Ceramide enables fas to cap and kill. J. Biol. Chem. 276:23954-23961.
91. Perry, D. K. and Hannun, Y. A. 1999. The use of diglyceride kinase for quantifying ceramide. Trends Biochem. Sci. 24: 226-227.
92. Kono, K., Tanaka, M., Ogita, T., Hosoya, T., and Kohama, T. 2000. F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete. J. Antibiot. (Tokyo) 53:459-466.
93. Kono, K., Tanaka, M., Ogita, T., and Kohama, T. 2000. Characterization of B-5354c, a new sphingosine kinase inhibitor, produced by a marine bacterium. J. Antibiot. (Tokyo) 53: 759-764.